Diurnal, Seasonal, and Monthly Variations in Ventricular Arrhythmias in Patients With Implantable Cardioverter-Defibrillators

被引:3
|
作者
Maan, Abhishek [1 ]
Sherfesee, Lou [2 ]
Lexcen, Daniel [2 ]
Heist, E. Kevin [1 ]
Cheng, Alan [2 ]
机构
[1] Massachusetts Gen Hosp, Cardiac Arrhythmia Serv, Boston, MA USA
[2] Medtron, 8200 Coral Sea St,MVS 2, Mounds View, MN 55112 USA
关键词
defibrillators; diurnal variation; ventricular arrhythmias; SUDDEN CARDIAC DEATH; CIRCADIAN VARIATION; MYOCARDIAL-INFARCTION; TACHYARRHYTHMIAS; TACHYCARDIA; MORTALITY; PLATELET; CORONARY; INTERVAL; THERAPY;
D O I
10.1016/j.jacep.2019.05.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The aim of this study was to assess the variations in ventricular arrhythmia (VA) occurrence according to seasons, months of the year, days of the week, and the time of day in a large implantable cardioverter-defibrillator patient population. BACKGROUND Limited data exist on how VA occurrence varies as a function of time. METHODS Data from 6 prospective studies were pooled to assess VA frequency over time. All adjudicated episodes of VAs <= 500 ms were included. VA distribution as a function of hour, day, month, and season were assessed through the construction of 4 negative binomial models. The models included a random patient effect and offset for days spent in each time period. RESULTS Among 3,969 patients, 7,126.8 cumulative device-years with an average follow-up duration of 1.8 +/- 1.4 years/patient were analyzed. VA occurrence was higher in the spring than the summer (0.86% vs. 0.70%; p = 0.009) but not significantly different from the fall (0.74%; p = 0.069) or winter (0.84%; p = 0.732). The estimated probability of occurrence of at least 1 VA episode in each 1-h block during the hours of 8 AM to 10 PM over 365 days (0.10% to 0.12%) was higher (estimated 35% to 63% higher) than the referent period of midnight to 1 AM (0.07%). No significant variations in VA occurrence were observed according to weekday and individual months of the year. CONCLUSIONS Significantly higher VA occurrence in the spring and during the hours of 8 AM to 10 PM were observed. Additional studies are needed to further understand the reasons for these observations, which may involve variations in temperature or differences in catecholamine triggers. (C) 2019 by the American College of Cardiology Foundation.
引用
收藏
页码:979 / 986
页数:8
相关论文
共 50 条
  • [31] Primary Prevention Implantable Cardioverter-Defibrillators in Ischemic Cardiomyopathy
    Rathod, Vrijraj S.
    Stiles, Martin
    CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2022, 24 (07) : 123 - 136
  • [32] Implantable cardioverter-defibrillators: a long-term view
    Wilson, D.
    Shi, B.
    Harding, S.
    Lever, N.
    Larsen, P.
    INTERNAL MEDICINE JOURNAL, 2012, 42 (05) : 554 - 561
  • [33] Electrical Storm in Patients with Implantable Cardioverter-Defibrillators Can It Be Forecast?
    Emkanjoo, Zahra
    Alihasani, Narges
    Alizadeh, Abolfath
    Tayyebi, Mohammad
    Bonakdar, Hamid
    Barakpour, Hamid
    Sadr-Ameli, Mohammad Ali
    TEXAS HEART INSTITUTE JOURNAL, 2009, 36 (06) : 563 - 567
  • [34] Characteristics of the phenotype of mixed cardiomyopathy in patients with implantable cardioverter-defibrillators
    Raja, Deep Chandh
    Samarawickrema, Indira
    Menon, Sarat Krishna
    Singh, Rikvin
    Mehta, Abhinav
    Tuan, Lukah Q. Q.
    Pandurangi, Ulhas
    Jain, Sanjiv
    Callans, David J. J.
    Marchlinski, Francis E. E.
    Abhayaratna, Walter P. P.
    Sanders, Prashanthan
    Pathak, Rajeev K. K.
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2024, 67 (01) : 129 - 137
  • [35] Implantable cardioverter-defibrillators in congenital heart disease
    Mondesert, Blandine
    Khairy, Paul
    CURRENT OPINION IN CARDIOLOGY, 2014, 29 (01) : 45 - 52
  • [36] Implantable cardioverter-defibrillators for treatment of sustained ventricular arrhythmias in patients with Chagas' heart disease: comparison with a control group treated with amiodarone alone
    Gali, Wagner L.
    Sarabanda, Alvaro V.
    Baggio, Jose M.
    Ferreira, Luis G.
    Gomes, Gustavo G.
    Antonio Marin-Neto, J.
    Junqueira, Luiz F.
    EUROPACE, 2014, 16 (05): : 674 - 680
  • [37] Clinical experience with subcutaneous implantable cardioverter-defibrillators
    Lewis, Geoffrey F.
    Gold, Michael R.
    NATURE REVIEWS CARDIOLOGY, 2015, 12 (07) : 398 - 405
  • [38] Primary Prevention Implantable Cardioverter-Defibrillators in Older Racial and Ethnic Minority Patients
    Pokorney, Sean D.
    Hellkamp, Anne S.
    Yancy, Clyde W.
    Curtis, Lesley H.
    Hammill, Stephen C.
    Peterson, Eric D.
    Masoudi, Frederick A.
    Bhatt, Deepak L.
    Al-Khalidi, Hussein R.
    Heidenreich, Paul A.
    Anstrom, Kevin J.
    Fonarow, Gregg C.
    Al-Khatib, Sana M.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2015, 8 (01): : 145 - U215
  • [39] Utilization and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Hypertrophic Cardiomyopathy
    Goldstein, Sarah A.
    Kennedy, Kevin F.
    Friedman, Daniel J.
    Al-Khatib, Sana M.
    Wang, Andrew
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (16):
  • [40] Effectiveness of Implantable Cardioverter-Defibrillators to Reduce Mortality in Patients With Long QT Syndrome
    Wang, Meng
    Peterson, Derick R.
    Rosero, Spencer
    McNitt, Scott
    Rich, David Q.
    Seplaki, Christopher L.
    Polonsky, Bronislava
    Goldenberg, Ilan
    Zareba, Wojciech
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 78 (21) : 2076 - 2088